Description

5,6-Dihydro-2,3-Dimethoxy-6,6-Dimethylbenz[7,8]Indolizino[2,3-B]Quinoxaline is a complex heterocyclic organic compound with a fused polycyclic structure, making it a valuable advanced intermediate in specialized chemical synthesis. This compound matters for its role as a key building block in the research and development of novel materials and active pharmaceutical ingredients (APIs). It is primarily needed by R&D chemists and process development scientists in the pharmaceutical, agrochemical, and advanced materials industries for constructing sophisticated molecular architectures.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the synthesis of complex drug candidates, particularly those targeting neurological or oncological pathways.
• Agrochemical Research: Used in the development of new-generation herbicides or pesticides with novel modes of action.
• Organic Light-Emitting Diode (OLED) Materials: Acts as a potential core structure for electron-transport or host materials in OLED device fabrication due to its rigid, conjugated framework.
• Dye and Pigment Synthesis: Employed as an intermediate for creating specialized dyes with specific optical properties.
• Academic and Industrial R&D: Utilized in methodological studies and as a building block for novel heterocyclic compounds in research laboratories.
• Ligand Synthesis for Catalysis: The nitrogen-rich structure can be functionalized to create novel ligands for transition metal catalysis.

Basic Information

Item	Details
Product Name	5,6-Dihydro-2,3-Dimethoxy-6,6-Dimethylbenz[7,8]Indolizino[2,3-B]Quinoxaline
CAS No.	163769-88-8
Molecular Formula	C23H24N2O2
Molecular Weight	360.45 g/mol
Synonyms	5,6-Dihydro-2,3-dimethoxy-6,6-dimethylbenz[7,8]indolizino[2,3-b]quinoxaline; 6,6-Dimethyl-5,6-dihydro-2,3-dimethoxybenz[7,8]indolizino[2,3-b]quinoxaline; Benz[7,8]indolizino[2,3-b]quinoxaline, 5,6-dihydro-2,3-dimethoxy-6,6-dimethyl-; CAS 163769-88-8
EINECS	Contact for details

Quality Control

Our 5,6-Dihydro-2,3-Dimethoxy-6,6-Dimethylbenz[7,8]Indolizino[2,3-B]Quinoxaline is produced under strict quality management protocols. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets the high standards required for research and development applications. Certificates of Analysis (COA) documenting batch-specific results are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep away from heat, sparks, and open flame. This material is light-sensitive (store away from light).

Specification

Item	Specification
Appearance	Yellow to brown powder or crystalline solid
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 95%
Loss on Drying	≤ 1.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.